Leadership in health care private equity since 1986

Tullis funds

Tullis has invested in more than sixty five portfolio companies across six professionally managed private equity funds, covering all sectors of the health care industry.


May 20, 2019 UCB announces N

NAYZILAM® (midazolam) nasal spray* is a nasally administered benzodiazepine...

April 24, 2019 Exagen's New Bi

Lupus Patients with Elevated PC4d Levels Have Significantly Increased Occurrence...

April 15, 2019 Alphatec Announ

Experienced Spine Executive David Sponsel Assumes Sales Leadership Role